Journals / Turkish Neurosurgery / 2020 / Cilt: 30 - Sayı: 4

Trends on Central Nervous System Cancers in Turkey

Pages
527–531
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On the other hand, developing treatment modalities and post-treatment care strategies mayreduce the mortality in these group of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To share the inferences about trends on central nervous system (CNS) cancers in Turkey with the whole health community.MATERIAL and METHODS: Turkish National Cancer Statistics, statistics of Turkey in GLOBOCAN 2018 and worldwide statisticscountry-by-country in GLOBOCAN 2018 was compared to reach a summary on this topic.RESULTS: CNS tumors are 10th comman in cancers in men with 5.2 for per 100.000.
📊
Key Findings & Data:Also, in women group, CNS tumors’ rate is 4.1for per 100.000 and take the 9th place of mostly seen first ten neoplasms.
💡
Conclusion & Impact:On the other hand, developing treatment modalities and post-treatment care strategies mayreduce the mortality in these group of patients.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To share the inferences about trends on central nervous system (CNS) cancers in Turkey with the whole health community.MATERIAL and METHODS: Turkish National Cancer Statistics, statistics of Turkey in GLOBOCAN 2018 and worldwide statisticscountry-by-country in GLOBOCAN 2018 was compared to reach a summary on this topic.RESULTS: CNS tumors are 10th comman in cancers in men with 5.2 for per 100.000. Also, in women group, CNS tumors’ rate is 4.1for per 100.000 and take the 9th place of mostly seen first ten neoplasms. In general, the incidence of CNS cancers in women in ourcountry is less than men as in the whole World. Turkish data between the years of 2010-2014 has shown that there is no significantdifference for both sexes.CONCLUSION: Although CNS cancers do not have high incidence rates, they have important mortality rates and, they consistone of a serious cause of death. Increase in the lifetime, exposure to environmental factors for the longer time, increasing usageof radioactive materials in our lives, easier access to healthcare systems and developing diagnosing possibilities may rise theincidence rates on CNS in the future. On the other hand, developing treatment modalities and post-treatment care strategies mayreduce the mortality in these group of patients.

🔖

Cite This Article

KUCUKYILDIZ, H. C. (2020). Trends on Central Nervous System Cancers in Turkey. Turkish Neurosurgery, Cilt: 30 - Sayı: 4, 527–531. https://ajindex.com/articles/404312

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group: Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023-1075, 2018 2. Bray F, Ferlay J, Soerjomataram I, Siegel Rl, Torre lA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394-324, 2018 3. Cahoon EK, Inskip PD, Gridley G, Brenner AV: Immunerelated conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans. British Journal of Cancer 110(7):1825, 2014 4. Davis DL, Ahlbom A, Hoel D, Percy C: Is brain cancer mortality increasing in industrial countries?. American Journal of Industrial Medicine 19(4):421-431, 1991 5. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurgical Focus 20(4):E1, 2006 6. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F: Global cancer observatory: Cancer today. Lyon: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed [31.03.2019]. 7. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359-386, 2015 8. Hoffman S: Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro-Oncol 8(1):27–37, 2006 9. Keskinkilic B, Gultekin M, Karaca AS: Cancer recording. In: Turkey Cancer Control Programme. Ankara: Anil Reklam Matbaa Ltd Sti, 2016:23Y31 10. Kim SJ, Ioannides SJ, Elwood JM: Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010. Aust N Z J Public Health 39(2):148–152, 2015 11. McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ: The impact of age and gender on the incidence of glial tumors in New York state from 1976–1995. Journal of Neurosurgery 93(6):932-939, 2000 12. Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, B